Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism

Abstract

In most cases symptoms of autism begin in early infancy. However, a subset of children appears to develop normally until a clear deterioration is observed. Many parents of children with "regressive"-onset autism have noted antecedent antibiotic exposure followed by chronic diarrhea. We speculated that, in a subgroup of children, disruption of indigenous gut flora might promote colonization by one or more neurotoxin-producing bacteria, contributing, at least in part, to their autistic symptomatology. To help test this hypothesis, 11 children with regressive-onset autism were recruited for an intervention trial using a minimally absorbed oral antibiotic. Entry criteria included antecedent broad-spectrum antimicrobial exposure followed by chronic persistent diarrhea, deterioration of previously acquired skills, and then autistic features. Short-term improvement was noted using multiple pre- and post-therapy evaluations. These included coded, paired videotapes scored by a clinical psychologist blinded to treatment status; these noted improvement in 8 of 10 children studied. Unfortunately, these gains had largely waned at follow-up. Although the protocol used is not suggested as useful therapy, these results indicate that a possible gut flora-brain connection warrants further investigation, as it might lead to greater pathophysiologic insight and meaningful prevention or treatment in a subset of children with autism. (J Child Neurol 2000;15:429-435).

Overview

Integrity signals

Registry

Crossref · 10.1177/088307380001500701

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

1 retracted

Show all 42 references

Research works printed but not linked: 5

  1. Kanner L., 1943, Nerv Child, 2, 217
  2. Rutter M., 1970, Semin Psychiatry, 2, 435
  3. Alpern G., 1995, Los Angeles, Western Psychological Services,
  4. Schopler E., 1995, The Autism Rating Scale Manual
  5. Conway P.: Microbial ecology of the human large intestine, in Gibson G, Macfarlane G (eds): Human Colonic Bacteria—Role in Nutrition, Physiology, and Pathology . Boca Raton, FL, CRC Press, 1995, pp 1-24.

Cited by

See all 671

Metadata

Authors
Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Väisänen, M.-L., Nelson, M. N., & Wexler, H. M.
Affiliations
  • Rush University Medical Center (US)
  • University of California, Los Angeles (US)
  • Sections of Pediatric Gastroenterology and Nutrition
  • Rush Children's Hospital (US)
Corresponding author
Sandler, Richard H.
Venue
Journal of Child Neurology
Published
2000-07
Volume
15
Issue
7
Pages
429-435
ISSN
  • 0883-0738 (ISSN-L)
  • 1708-8283
OpenAlex
W2020523926
Cited by
614
References
42
Citations by year
2026: 10 · 2025: 22 · 2024: 24 · 2023: 38 · 2022: 40 · 2021: 50 · 2020: 47 · 2019: 45 · 2018: 43 · 2017: 25 · 2016: 34 · 2015: 36 · 2014: 25 · 2013: 29 · 2012: 26
FWCI
4.88
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Child Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Pfizer Pharmaceuticals
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
Keywords
oral vancomycin, gut microbiota, antibiotic exposure, chronic diarrhea, gut-brain axis, autism treatment, behavioral interventions
MeSH terms
Administration, Oral, Autistic Disorder, Bacteria, Child, Child, Preschool, Dose-Response Relationship, Drug, Drug Administration Schedule, Feces, Female, Humans, Intestinal Mucosa, Male, Neuropsychological Tests, Regression, Psychology, Vancomycin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism. https://app.cochat.ai/papers/10.1177/088307380001500701
The paper
Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Väisänen, M.-L., Nelson, M. N., & Wexler, H. M. (2000). Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism. Journal of Child Neurology. https://doi.org/10.1177/088307380001500701

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.